Summit Healthcare Acquisition Corp.
Completed 2023-03-16- CIK 1839185
- SMIH
- Now YS
- IPO 2021-06-10
- $201M trust
- 70 filings
Successfully merged with YS Biopharma Co., Ltd. • Now trading as YS
- IPO Size
- $200M
- raised at the IPO
- Trust
- $201M
- as of 2022-09-30
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2021
- year it listed
Filings, by quarter
70 filings over 9 quarters; violet bars carry a milestone
- 21 Q1: 2 filings
- 21 Q2: 27 filings
- 21 Q3: 3 filings
- 21 Q4: 3 filings
- 22 Q1: 5 filings
- 22 Q2: 1 filing
- 22 Q3: 5 filings
- 22 Q4: 1 filing
- 23 Q1: 23 filings
- S-1 filed 21 Q1
- IPO 21 Q2
- Definitive agreement 22 Q3
- Completed 23 Q1
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Summit Healthcare Acquisition Corp. is a blank-check company seeking a business combination, with an intended focus on healthcare and assets with a strong China nexus. Its target search includes pharmaceutical, medtech and diagnostics businesses.
Investment Focus
Healthcare
Geographic Focus
China
Key Information
As the filings state it
- IPO Date
- 2021-06-10
- Total Redemptions
- $196M
- PIPE
- $30M
- Jurisdiction of Incorporation
- Cayman Islands
- SIC
- 6770
- Completion Date
- 2023-03-16
- Merger Target
- YS Biopharma Co., Ltd.
- SPAC Ticker
- SMIH
- Merged Ticker
- YS
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Bo Tan and Ken Poon bring extensive healthcare, pharmaceutical, capital-markets and transaction experience; senior advisor Wei Fu has founded and led healthcare-focused private equity firm CBC Group. The director nominees have backgrounds in telecom, media, finance, pharmaceutical business development and law.